Purple Biotech Ltd.PPBTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank73
3Y CAGR-13.6%
5Y CAGR+27.3%
Year-over-Year Change
Research and development spending
3Y CAGR
-13.6%/yr
vs +26.4%/yr prior
5Y CAGR
+27.3%/yr
Recent deceleration
Acceleration
-40.0pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
3.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $7.62M | -55.3% |
| 2023 | $17.03M | +4.4% |
| 2022 | $16.32M | +38.0% |
| 2021 | $11.83M | +57.9% |
| 2020 | $7.49M | +228.7% |
| 2019 | $2.28M | -56.8% |
| 2018 | $5.27M | +13.5% |
| 2017 | $4.64M | +11.0% |
| 2016 | $4.18M | +63.3% |
| 2015 | $2.56M | - |